1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Regulation

Natural Cycles Fertility App Wins FDA Clearance For Oura Ring Integration

 
• By Elizabeth Orr

The app, the first to be approved with a birth control indication, can now sync data directly from the Oura Ring, a wearable device that tracks user’s biometrics.

Smiling young woman holding smartphone and wearing Oura Ring.
• Source: Natural Cycles

Women who use fertility management app Natural Cycles can now use an Oura Ring to track their body temperature, putting an end to the need to manually take and record their temperature each day.

That’s thanks to a partnership between Natural Cycles and ŌURA Health announced on 2 August. The US Food and Drug Administration has cleared the integration of the two devices, allowing...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.